MayTech Global Investments’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.8M Sell
299,552
-5,597
-2% -$390K 2.29% 17
2025
Q4
$20.3M Sell
305,149
-2,598
-0.8% -$168K 2.05% 19
2025
Q3
$20.7M Sell
307,747
-2,884
-0.9% -$228K 2.16% 19
2025
Q2
$26.7M Buy
310,631
+20,818
+7% +$1.63M 2.76% 16
2025
Q1
$19.8M Buy
289,813
+9,047
+3% +$738K 2.57% 17
2024
Q4
$21.8M Buy
280,766
+21,509
+8% +$1.59M 2.57% 17
2024
Q3
$17.4M Buy
259,257
+90,498
+54% +$7.43M 2.3% 16
2024
Q2
$19.1M Buy
168,759
+3,511
+2% +$444K 2.87% 15
2024
Q1
$22.9M Buy
165,248
+2,396
+1% +$301K 3.75% 12
2023
Q4
$20.2M Buy
162,852
+1,151
+0.7% +$118K 4.09% 12
2023
Q3
$15.1M Buy
161,701
+28,125
+21% +$3.17M 3.51% 14
2023
Q2
$17.2M Buy
133,576
+17,194
+15% +$2.08M 3.4% 14
2023
Q1
$13.5M Sell
116,382
-4,067
-3% -$455K 3.72% 12
2022
Q4
$13.6M Buy
120,449
+10,608
+10% +$1.16M 4.52% 10
2022
Q3
$8.85M Sell
109,841
-2,843
-3% -$241K 3.23% 15
2022
Q2
$8.4M Buy
112,684
+1,556
+1% +$142K 2.66% 16
2022
Q1
$14.2M Sell
111,128
-47,816
-30% -$5.23M 3.27% 14
2021
Q4
$21.3M Buy
158,944
+1,184
+0.8% +$170K 4.29% 11
2021
Q3
$21.6M Buy
157,760
+1,380
+0.9% +$174K 4.47% 11
2021
Q2
$16.7M Buy
156,380
+2,016
+1% +$194K 3.49% 14
2021
Q1
$13.9M Buy
154,364
+1,424
+0.9% +$134K 3.33% 13
2020
Q4
$14.1M Buy
152,940
+4,168
+3% +$372K 3.36% 15
2020
Q3
$15.3M Buy
148,772
+2,960
+2% +$309K 4.1% 11
2020
Q2
$14.8M Sell
145,812
-22,204
-13% -$1.99M 4.64% 9
2020
Q1
$11.3M Sell
168,016
-19,440
-10% -$1.21M 5.17% 7
2019
Q4
$10.3M Buy
187,456
+12
+0% +$569 4.46% 11
2019
Q3
$6.99M Buy
187,444
+5,984
+3% +$232K 3.45% 12
2019
Q2
$6.8M Buy
181,460
+3,736
+2% +$117K 3.41% 14
2019
Q1
$5.29M Buy
177,724
+1,260
+0.7% +$44.3K 2.79% 17
2018
Q4
$5.29M Buy
176,464
+8,656
+5% +$275K 3.39% 15
2018
Q3
$6M Buy
+167,808
New +$5.2M 2.92% 16

Other funds holding DXCM

MayTech Global Investments's DXCM Position: Q1 2026 in Review

MayTech Global Investments reduced its DexCom (DXCM) stake by 1.8% in Q1 2026, selling an estimated $390K and leaving 299,552 shares worth $18.8M. The position accounts for 2.29% of the portfolio, ranked #17.

MayTech Global Investments first reported a position in DXCM in Q3 2018 and has held it in 31 quarters since. The position peaked at $26.7M in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • MayTech Global Investments held 299,552 shares of DexCom worth $18.8M as of Q1 2026.
  • MayTech Global Investments sold 5,597 DexCom shares in Q1 2026, an estimated $390K.
  • DexCom made up 2.29% of MayTech Global Investments's portfolio in Q1 2026, its #17 holding.
  • MayTech Global Investments first reported a position in DexCom in Q3 2018 and has held it in 31 quarters since.
  • MayTech Global Investments's DexCom position peaked at $26.7M in Q2 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on MayTech Global Investments's 13F filing for Q1 2026, filed 14 May 2026.